Dr. Kaczmar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
SC State Medical License 2016 - 2025
MO State Medical License 2016 - 2018
PA State Medical License 2010 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 42 citationsPhase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, Benjamin H Hinrichs, Francis P Worden
Clinical Cancer Research. 2022-04-01 - 16 citationsDevelopment and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head...Evan M. Graboyes, Katherine R. Sterba, Hong Li, Graham W. Warren, Anthony J. Alberg
JCO Oncology Practice. 2021-03-10 - 28 citationsBarriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer.Evan M. Graboyes, Chanita Hughes Halbert, Hong Li, Graham W. Warren, Anthony J. Alberg
JCO Oncology Practice. 2020-08-27
Press Mentions
Studies Show How to Boost Immunotherapy Effectiveness for Patients with Oral-Cavity Squamous Cell CarcinomaNovember 5th, 2021- Clinical Trial Gets Oral Cancer Survivor Through 'Mean' CancerDecember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
